FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text' The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.
Open in BitSocialBitSocial — the social app with no off switch